Anavex Life Sciences Corp. (AVXL)
Market Closed
17 Jul, 20:00
$
2. 39
+0.05
+2.1368%
$
231.68M Market Cap
- P/E Ratio
- Div Yield
1.92M Volume
-0.63 Eps
$ 2.34
Previous Close 
Want to track AVXL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anavex Life Sciences Corp. (AVXL) Statistics
Valuation metrics
Market Cap 231.68M
Enterprise value 89.74M
Trailing P/E (ttm) -5.15
Forward P/E -25
PEG ratio -0.31
Price/Sales (ttm) -
Price/Book (mrq) 1.68
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.31
Overview
Shares outstanding 92.67M
Float 89.78M
Shares short 19.26M
% Held by insiders 0.03%
% Held by institutions 0.42%
Average volume (10 days) 1.3M
Average volume (90 days) 1.01M
Price summary
52-Week low 2.25
52-Week high 13.99
Beta 1.18
50-Day moving average 2.6
200-Day moving average 3.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 7 Oct 2015
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.3%
Return on equity -0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -39.95M
Diluted EPS (ttm) -0.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 131.75M
Total cash per share (mrq) 1.48
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 20.87%
Book value per share (mrq) 1.42
Cash Flow
Cash flow statement -34.08M
Levered free cash flow (LFCF) -21.83M
